The "Blood-Black Toxin" And Treatment Of Childrens' Henoch-Schonlein Purpura

Objective: This subject study the pathogenesis and treatment of Henoch-Schonlein purpura of children from "blood-black toxin", in order to look for new theory of pathogeny and therapeutics in traditional Chinese medicine. It can make treatment by "blood-black toxin" become a new way, for that improving clinical curative effect, reducing the complications, shorting course of the disease, reducing recrudesce.Method: We collect the cases of patients who are in hospital of TCM in Jiangsu Province from 2007-2008, and establish studying standards, and screen 49 cases up to standard in the end; We observe the coincidence between the symptoms of the cases collected and "blood-black toxin", study pathogenesis of "blood-black toxin"; We extract prescription, and sum up drugs in common use and representative therapeutics of that. We analyse the internal principium of the therapeutics, statistic the match relation of the therapeutic in the prescription, in order to seek applying of treatment by "blood-black toxin".Results: Clinical manifestations of the disease in line with the characteristics of "blood-black toxin", and "blood-black toxin" run through all the courses of it. "toxin" usually cause the disease along with wind, heat, blood-black and wet. The special therapeutics of "toxin" including detoxification, draining toxin and resisting toxin. They are usual cold blood and detoxification, clearing heat and detoxification, eliminating dampness and detoxification, diuresis and detoxification. The special therapeutics of "blood-black" including activating blood circulation to dissipate blood stasis, freeing channel and resolving hard lump, they usually match with clear heat, cold blood, arrest blood, particularly in the areas of heat and cooling blood treatment for many. Furthermore, we use along with other treatment according to state. Conclusion: "blood-black toxin" is one of pathogeny factors. Chinese medicine treatment of this disease emphasize the special therapeutics of "blood-black toxin", in order to improve clinical efficacy.